Rank: Newbie
Groups: Member
Joined: 11/11/2007
Posts: 1
|
A few years back, when the San Diego State University (SDSU) was contemplating the design of an M.S. degree program in regulatory affairs, only two such programs were available in the United States. Both of the universities offering these degrees were located on the East Coast, in the heart of the pharmaceutical industry, and both programs originated within existing departments of pharmacy. Such industry influences and departmental connections explained why the M.S. program in quality assurance and Regulatory affairs at Temple University (Philadelphia, Pennsylvania) and the M.S. program in drug regulatory affairs at Long Island University (Brooklyn, New York) focused primarily on pharmaceuticals.
The influence of local industry also played a role in shaping SDSU's regulatory affairs degree program, but with quite different results. SDSU is located in a county that is home to more than 350 companies involved in health care product R&D.
In contrast to the overwhelming concentration of pharmaceutical companies found on the East Coast, San Diego County's health care product companies are more or less evenly distributed among all aspects of the health care spectrum, including pharmaceuticals, biologics and biotechnology, and medical device companies.
To summarize, the pharmaceutical drug industry depends upon Regulatory affairs professionals to provide necessary regulatory information about health products. Their work continues to benefit consumers worldwide.
|
